Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Assets (2016 - 2025)

Jaguar Health (JAGX) has disclosed Assets for 11 consecutive years, with $38.3 million as the latest value for Q4 2025.

  • Quarterly Assets fell 28.27% to $38.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.3 million through Dec 2025, down 28.27% year-over-year, with the annual reading at $38.3 million for FY2025, 28.27% down from the prior year.
  • Assets for Q4 2025 was $38.3 million at Jaguar Health, down from $49.5 million in the prior quarter.
  • The five-year high for Assets was $69.5 million in Q2 2021, with the low at $38.3 million in Q4 2025.
  • Average Assets over 5 years is $53.7 million, with a median of $52.5 million recorded in 2022.
  • The sharpest move saw Assets surged 106.49% in 2021, then decreased 28.27% in 2025.
  • Over 5 years, Assets stood at $53.3 million in 2021, then decreased by 10.91% to $47.5 million in 2022, then increased by 6.98% to $50.8 million in 2023, then increased by 5.24% to $53.4 million in 2024, then fell by 28.27% to $38.3 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $38.3 million, $49.5 million, and $48.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.